Skip to main content

Table 1 Associations between FBP1 and -3 and clinical parameters in prostate cancer (low, high expression: for definition see text).

From: The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer

  FPB1 FBP3
  n low
n (%)
high
n(%)
p-value n low
n (%)
high
n(%)
p-value
pT2 42 29 (69.0) 13
(31.0)
n.s. 44 31
(70.5)
13
(29.5)
n.s.
pT3/4 49 33
(67.3)
16
(32.7)
  51 35
(68.6)
16
(31.4)
 
Gleason score 2–6 23 16
(69.6)
7
(30.4)
n.s. 24 14
(58.3)
10
(41.7)
n.s.
Gleason score 7–10 67 46
(68.7)
21
(31.3)
  70 51
(72.9)
19
(27.1)
 
PSA relapse 48 34
(70.8)
14
(29.2)
n.s. 49 32
(65.3)
17
(34.7)
n.s.
No PSA relapse 43 28
(65.1)
15
(34.9)
  46 34
(73.9)
12
(26.1)
 
FBP1 low 62     62 48
(77.4)
14
(22.6)
0.017
FBP1 high 29     29 15
(51.7)
14
(48.3)
 
FBP3 low 63 48
(76.2)
15
(23.8)
0.017 66    
FBP3 high 28 14
(50.0)
14
(50.0)
  29    
  1. n.s.: not significant